Market Cap | 304.01M | P/E | - | EPS this Y | -3.60% | Ern Qtrly Grth | - |
Income | -153.78M | Forward P/E | -6.98 | EPS next Y | 24.60% | 50D Avg Chg | 11.00% |
Sales | 80.97M | PEG | - | EPS past 5Y | - | 200D Avg Chg | 15.00% |
Dividend | N/A | Price/Book | 1.66 | EPS next 5Y | - | 52W High Chg | -63.00% |
Recommedations | 3.00 | Quick Ratio | 3.00 | Shares Outstanding | 101.34M | 52W Low Chg | 444.00% |
Insider Own | 12.84% | ROA | -22.26% | Shares Float | 48.23M | Beta | -1.45 |
Inst Own | 73.26% | ROE | -98.14% | Shares Shorted/Prior | 1.80M/1.83M | Price | 3.00 |
Gross Margin | 32.59% | Profit Margin | -77.17% | Avg. Volume | 1,377,340 | Target Price | 3.00 |
Oper. Margin | -71.25% | Earnings Date | May 11 | Volume | 946,546 | Change | 0.00% |
SOC Telemed, Inc. provides acute care telemedicine services and technology to hospitals, health systems, physician groups, and government organizations in the United States. The company's Telemed IQ, a cloud-based software platform provides telemedicine solutions. Its telemedicine solutions include teleNeurology, telePulmonology, telePsychiatry, telecardiology, teleCritical Care (ICU), and other specialties. The company was founded in 2004 and is based in Herndon, Virginia. As of April 6, 2022, SOC Telemed, Inc. was taken private.
Credit Suisse | Neutral | Feb 7, 22 |
Benchmark | Hold | Feb 4, 22 |
RBC Capital | Sector Perform | Feb 3, 22 |
Baird | Neutral | Feb 3, 22 |
Credit Suisse | Neutral | Jan 7, 22 |
RBC Capital | Outperform | Aug 13, 21 |
Credit Suisse | Outperform | Aug 13, 21 |
Baird | Outperform | May 28, 21 |
Credit Suisse | Outperform | Feb 16, 21 |